Who Should Pay for Really Expensive Drugs?
Who Should Pay for Really Expensive Drugs?
When is the last time you saw a news headline about cancer patients who died because they were unable to afford a drug that could have saved their lives? I bet you haven’t. One reason is that drug companies that make expensive drugs can’t afford the political backlash that would follow such a headline. Another...
By John C. Goodman
Medicare Advantage Is Saving Taxpayers Money
Medicare Advantage Is Saving Taxpayers Money
A new study finds that the migration of people from traditional Medicare to the Medicare Advantage program over the last decade has saved the federal government $144 billion. The study arrives at a time when critics have stepped up their claims that Medicare Advantage (MA) plans are over-billing Medicare and causing a waste of taxpayer...
By John C. Goodman
Why Lower-Income Workers Are Trending Republican
Why Lower-Income Workers Are Trending Republican
It’s hard to be an economist and, at the same time, be a Democrat. The reason? Most left-leaning Democrats reject the main teachings of economics. Yet more than 80% of academic economists are Democrats. For every Republican economist on college faculties, there are 4.5 Democrats. Consider just a few of the ways in which what...
By John C. Goodman
Why Health Policy Problems Rarely Get Solved
Why Health Policy Problems Rarely Get Solved
For at least half a century, we have been struggling with three health policy problems that never seem to go away: cost, quality and access to care. This is the case even though public policy has been actively trying to solve all three—with increasing aggressiveness through time. Over the past 50 years, medical science has...
By John C. Goodman